Why the study?
Adenovirus is an important cause of infectious complications after solid organ transplantation, prompting updated guidance on its diagnosis, prevention, and management.
These updated guidelines provide consensus recommendations for managing adenovirus infections in solid organ transplant recipients, emphasizing that routine surveillance in asymptomatic patients is unnecessary and highlighting supportive care and immunosuppression reduction as the mainstays of therapy.
Answers are grounded in this paper and cite their sources.
Updated adenovirus guidelines inform SOT management; leaves open need for prospective validation of recommendations.
These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of adenovirus infections after solid organ transplantation. Adenovirus is an important cause of infectious complications in both stem cell transplant and SOT patients, causing a range of clinical syndromes including pneumonitis, colitis, and disseminated disease. The current update of the guidelines highlights that adenovirus surveillance testing should not be performed in asymptomatic recipients. Serial quantitative PCR might play a role in the decision to initiate or assess response to therapy in a symptomatic patient. The initial and most important components of therapy remain supportive care and decrease in immunosuppression. The use of antiviral therapy is not supported by prospective randomized clinical trials. However, intravenous cidofovir is considered the standard practice for treatment of severe, progressive, or disseminated adenovirus disease in most transplant centers. Intravenous immunoglobulin may be beneficial, primarily in a select group of patients with hypogammaglobulinemia. Future approaches to treatment of adenovirus disease may include administration of adenovirus-specific T-cell therapy.
No takes yet. Share an insight, caveat, or question.
Florescu et al. (2019) conducted a review in Adenovirus infections after solid organ transplantation. Adenovirus management guidelines was evaluated. Updated guidelines recommend against adenovirus surveillance testing in asymptomatic solid organ transplant recipients and emphasize supportive care and decreased immunosuppression as primary therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: